What is the next step in managing a child with acute severe ulcerative colitis who has not responded to intravenous (IV) steroids for 5 days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Severe Ulcerative Colitis After Failed IV Steroid Therapy

For a child with acute severe ulcerative colitis who has not responded to 5 days of IV steroids, rescue therapy with infliximab should be initiated immediately, with consideration for surgical consultation if no improvement occurs within 5-7 days of rescue therapy.

Assessment of Steroid Failure

The lack of response to IV steroids after 5 days meets established criteria for steroid-refractory disease. According to the British Society of Gastroenterology guidelines, steroid failure is defined by:

  • On day 3: >8 stools per day or 3-8 stools with CRP >45 mg/L
  • On day 7: >3 stools per day or visible blood
  • For pediatric patients: PUCAI score >65 on day 5 1

Additional severity indicators include:

  • Mucosal islands on abdominal X-ray
  • Colonic dilatation
  • Deep ulceration on flexible sigmoidoscopy 1

Recommended Rescue Therapy

First-line Rescue Option: Infliximab

Infliximab is recommended as the preferred rescue therapy for several reasons:

  1. Established efficacy in steroid-refractory ASUC in pediatric patients 1
  2. FDA-approved for pediatric ulcerative colitis from age 6 and above 2
  3. Standard dosing: 5 mg/kg IV at weeks 0,2, and 6, followed by maintenance every 8 weeks 2
  4. Better long-term outcomes compared to ciclosporin 1

For patients with low serum albumin or high inflammatory burden, consider an intensified dosing regimen after surgical consultation 1.

Alternative Rescue Option: Ciclosporin

Ciclosporin (2 mg/kg/day IV) can be considered as an alternative rescue therapy, particularly in:

  • Infliximab-contraindicated patients
  • Patients with previous infliximab exposure 1

However, ciclosporin should NOT be used in patients who have previously failed thiopurine therapy, as the colectomy rate is significantly higher (59%) in these patients 1.

Monitoring Response to Rescue Therapy

Close monitoring is essential during rescue therapy:

  • Daily clinical assessment
  • Regular laboratory tests (CBC, CRP, albumin)
  • Surgical consultation if no improvement within 48-72 hours of rescue therapy
  • Consider colectomy if no response after 5-7 days of rescue therapy 1

Surgical Considerations

Surgical consultation should be obtained early in the course of rescue therapy. Colectomy should be considered if:

  • No improvement after 5-7 days of rescue therapy
  • Clinical deterioration at any point
  • Development of complications (toxic megacolon, severe hemorrhage, perforation) 1

Delaying surgery in non-responders is associated with increased postoperative complications 1.

Maintenance Therapy After Successful Rescue

If the patient responds to infliximab rescue therapy:

  1. Complete the induction regimen (doses at weeks 0,2, and 6)
  2. Initiate maintenance therapy with infliximab (5 mg/kg every 8 weeks)
  3. Consider adding a thiopurine (if thiopurine-naïve) for combination therapy 1

Common Pitfalls to Avoid

  1. Delaying rescue therapy decision: Assess response to IV steroids by day 3-5 and initiate rescue therapy promptly if criteria for steroid failure are met
  2. Prolonged rescue attempts: Limit rescue therapy to 5-7 days before considering colectomy
  3. Overlooking infections: Screen for C. difficile and CMV infections, which can mimic or exacerbate ASUC
  4. Using ciclosporin in thiopurine-experienced patients: Higher failure rates make this a poor choice 1
  5. Inadequate VTE prophylaxis: Ensure low-molecular-weight heparin is administered 1

Special Considerations for Pediatric Patients

  • Use the Pediatric Ulcerative Colitis Activity Index (PUCAI) to assess disease severity
  • PUCAI >65 on day 5 of IV steroids indicates need for rescue therapy 1
  • Ensure appropriate weight-based dosing of medications
  • Consider nutritional support if malnourished 1

By following this algorithm, the management of steroid-refractory acute severe ulcerative colitis in children can be optimized to improve outcomes and reduce morbidity and mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the initial treatment approach for acute onset ulcerative colitis?
Why not use both intravenous (IV) steroids and rectal steroids for a patient with severe acute ulcerative colitis?
What is the best management plan for a 50-year-old patient with a 10-year history of Ulcerative Colitis (UC) presenting with severe acute UC and signs of toxic colitis, including bloody diarrhea, abdominal pain, tenderness, fever, anemia, leukocytosis, hypoalbuminemia, elevated Erythrocyte Sedimentation Rate (ESR), and elevated C-Reactive Protein (CRP)?
What is the best management plan for a patient with severe acute ulcerative colitis (UC) and toxic colitis, presenting with bloody diarrhea, abdominal pain, tenderness, fever, anemia, leukocytosis, hypoalbuminemia, and elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)?
What is the best management plan for a 50-year-old patient with a 10-year history of Ulcerative Colitis (UC) presenting with severe acute ulcerative colitis and toxic colitis, characterized by frequent bloody diarrhea, abdominal pain, tenderness, fever, anemia, leukocytosis, hypoalbuminemia, elevated Erythrocyte Sedimentation Rate (ESR), and elevated C-Reactive Protein (CRP)?
How do you lower your Hemoglobin A1C (HbA1c) levels?
What is the approach to Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA) surgery and anesthetic management?
Is metformin (biguanide) recommended for type 1 diabetes mellitus?
How to diagnose and manage presyncope in a 7-week pregnant patient?
How to manage watery semen in a patient with hyperthyroidism?
Is Mounjaro (tirzepatide) recommended for type 1 diabetes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.